Investments (#)


DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.


DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.

Recent transactions in the sector

Country Funding round Date
Judo Bio Inc
Developer of oligonucleotide medicines delivered to the kidney. 		United States Series A
USD 100,000,000 (USD 100,000,000) 		7 Oct 2024
Blend Therapeutics Inc
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. 		United States Series B
USD 21,000,000 (USD 21,000,000) 		7 Jan 2015
Blend Therapeutics Inc
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. 		United States Series A
 6 Jan 2012
Limula SA
 Switzerland N/A
Limula SA
 Switzerland N/A
Limula SA
 Switzerland N/A
Limula SA
 Switzerland N/A
Limula SA
 Switzerland N/A
Limula SA
 Switzerland N/A
Prokarium Ltd
Oral vaccine delivery platform. 		N/A

Best funded companies in the sector



Judo Bio Inc

United States

Developer of oligonucleotide medicines delivered to the kidney.



Blend Therapeutics Inc

United States

Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy.

Investment themes:
cancer treatment


Limula SA

Switzerland

Investment themes:
cell therapy


Prokarium Ltd


Oral vaccine delivery platform.

Investment themes:
vaccines, oral vaccines

Top investors in the Bio Therapeutic Drugs sector

Profile Country Investments
New Enterprise Associates Inc Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. United States 1
W.A. De Vigier Foundation 1
Alexandria Venture Investments 1
Eminent Venture Capital 1
Verve Capital Partners AG Switzerland 1
The Column Group 1
Zühlke Group 1
Droia Ventures Belgium 1
Lichtsteiner Foundation 1
Euclidean Capital 1
NanoDimension Management Ltd Cayman Islands 1
Korea Investment Partners Co Ltd Korea's largest venture capital firm. South Korea 1
YK Bioventures 1
Atlas Venture Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. United States 1
LifeX Ventures 1
TCG Capital Management LP 1
Oxford Seed Fund 1
Digitalis Ventures 1

Bio Therapeutic Drugs industry map

cell therapy
Limula SA

See all cell therapy
vaccines
Prokarium Ltd

See all vaccines
vaccines
Prokarium Ltd

See all vaccines
oral vaccines
Prokarium Ltd

See all oral vaccines
oral vaccines
Prokarium Ltd

See all oral vaccines

Bio Therapeutic Drugs selected deal sizes (USD)

Funding round Median Average Minimum Maximum Sample size
Series A 100,000,000 100,000,000 100,000,000 100,000,000 1
Series B 21,000,000 21,000,000 21,000,000 21,000,000 1
2

DISCLAIMER: This table is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.

Business Classification

Parent business classification group
Biotechnology & Medical Research